Plasma Levels of Soluble Urokinase-Type Plasminogen Activator Receptor Associate with the Clinical Severity of Acute Puumala Hantavirus Infection-Reference-Cited by-同舟云学术

Plasma Levels of Soluble Urokinase-Type Plasminogen Activator Receptor Associate with the Clinical Severity of Acute Puumala Hantavirus Infection

Published:2013-08-21 Issue:8 Volume:8 Page:e71335
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Outinen Tuula K.,Tervo Laura,Mäkelä Satu,Huttunen Reetta,Mäenpää Niina,Huhtala Heini,Vaheri Antti,Mustonen Jukka,Aittoniemi Janne

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Hantavirus infections in Europe;O Vapalahti;Lancet Infect Dis,2003

2. Hantavirus infections in Europe and their impact on public health;A Vaheri;Rev Med Virol,2013

3. Situation of hantavirus infections and haemorrhagic fever with renal syndrome in European countries as of December 2006;P Heyman;Euro Surveill,2008

4. Disease burden of Puumala virus infections, 1995–2008;P Makary;Epidemiol Infect,2010

5. Nephropathia epidemica in Finland. A clinical histological and epidemiological study;J Lähdevirta;Ann Clin Res,1971

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil‐to‐lymphocyte ratio is elevated in acute hantavirus infection and correlates with markers of disease severity;Journal of Medical Virology;2024-06

2. Factors of the hemostasis system as biomarkers of severe course of acute viral infections;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2024

3. Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants;Frontiers in Immunology;2023-06-14

4. suPAR to Risk-Stratify Patients With Malaria;Frontiers in Immunology;2022-06-10

5. Clinical and Immunological Predictors of Hemorrhagic Fever with Renal Syndrome Outcome during the Early Phase;Viruses;2022-03-14